Cambridge Oncology Seminar Series
This seminar series covers clinical, laboratory and translational aspects of cancer. It is jointly organised by researchers at the Cambridge Research Institute, the Addenbrooke's Hospital Clinical, Medical and Surgical Oncology departments and the Hutchison/MRC Research Centre.
The talks are open to all interested persons from the University of Cambridge, Cancer Research UK and Addenbrooke's Hospital. Members of the local pharma and biotechnology companies are also welcome to attend by prior arrangement with Laura Blackburn.
All talks take place on Tuesdays at 12 noon in the Sackler Lecture Theatre (Level 7, CIMR), the Max Perutz Lecture Theatre (MRC-LMB), or in the Cambridge Research Institute Lecture Theatre.
Seminars 2011-2012
DICER1 and miRNA processing - a novel paradigm in cancer predisposition
Speaker: Marc Tischkowitz, Department of Medical Genetics
Commissioning in the NHS
Speaker: Hannah Farrar, Director of Strategy and System Management, NHS London
Exploiting ASS1 deficiency in the treatment of mesothelioma
Speaker: Peter Szlosarek, Barts and The London
Economics of cancer medicines
Speaker: Richard Sullivan, King's College London
Lung cancer and phase 1 clinical trials
Speaker: Ross Camidge, University of Colorado Hospital and University of Colorado Cancer Centre
Note unusual time and day
Title to be confirmed
Speaker: Thomas Brunner, Gray Institute, Oxford
Title to be confirmed
Speaker: Sibylle Mittnacht, UCL Cancer Institute
Hutchison/MRC Research Centre Seminar
Pancreatic cancer
Speaker: Thorsten Hagemann, Barts Cancer Institute
Title to be confirmed
Speaker: Keith Flaherty, Massachusetts General Hospital
Note unusual day and time
Increase text
Decrease text
Print this page